 John Repine
Concepts (734)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neutrophils | 120 | 2005 | 1134 | 4.150 |
Why?
| | Interleukin-1 | 32 | 2015 | 961 | 2.770 |
Why?
| | Xanthine Oxidase | 43 | 2003 | 79 | 2.730 |
Why?
| | Lung | 93 | 2013 | 4109 | 2.440 |
Why?
| | Oxygen | 54 | 2016 | 995 | 2.380 |
Why?
| | Hydrogen Peroxide | 49 | 2002 | 336 | 2.050 |
Why?
| | Rats | 102 | 2015 | 5597 | 1.420 |
Why?
| | Catalase | 41 | 1997 | 130 | 1.270 |
Why?
| | Oxidative Stress | 12 | 2016 | 1339 | 1.260 |
Why?
| | Antioxidants | 13 | 2012 | 549 | 1.140 |
Why?
| | Superoxides | 28 | 1999 | 204 | 1.110 |
Why?
| | Pulmonary Edema | 23 | 1997 | 106 | 1.030 |
Why?
| | Thiourea | 29 | 1995 | 41 | 1.020 |
Why?
| | Macrophages, Alveolar | 4 | 2016 | 368 | 1.010 |
Why?
| | Rats, Sprague-Dawley | 38 | 2015 | 2527 | 0.960 |
Why?
| | Bronchoalveolar Lavage Fluid | 15 | 2016 | 636 | 0.910 |
Why?
| | Endothelium, Vascular | 16 | 2002 | 965 | 0.910 |
Why?
| | Ferritins | 5 | 2004 | 69 | 0.860 |
Why?
| | Animals | 173 | 2016 | 38058 | 0.840 |
Why?
| | Oxygen Inhalation Therapy | 2 | 2016 | 182 | 0.810 |
Why?
| | Xanthine Dehydrogenase | 14 | 1999 | 24 | 0.790 |
Why?
| | Ergothioneine | 2 | 2012 | 2 | 0.730 |
Why?
| | Lipopolysaccharides | 7 | 2015 | 863 | 0.690 |
Why?
| | Blood Bactericidal Activity | 21 | 1992 | 42 | 0.670 |
Why?
| | In Vitro Techniques | 46 | 2002 | 1047 | 0.660 |
Why?
| | Interferon Type I | 1 | 2021 | 145 | 0.630 |
Why?
| | Glutathione | 19 | 2000 | 375 | 0.620 |
Why?
| | Prostaglandins | 3 | 2019 | 94 | 0.610 |
Why?
| | Enzyme Inhibitors | 8 | 2004 | 824 | 0.600 |
Why?
| | Ischemia | 11 | 1997 | 421 | 0.600 |
Why?
| | Reperfusion Injury | 15 | 1997 | 300 | 0.590 |
Why?
| | Persian Gulf Syndrome | 1 | 2019 | 18 | 0.590 |
Why?
| | Chemokines, CXC | 6 | 2005 | 68 | 0.590 |
Why?
| | Leukotrienes | 1 | 2019 | 27 | 0.590 |
Why?
| | Free Radicals | 24 | 2008 | 110 | 0.580 |
Why?
| | Pulmonary Alveoli | 23 | 2011 | 383 | 0.580 |
Why?
| | Pneumonia | 6 | 2011 | 631 | 0.580 |
Why?
| | Capillary Permeability | 14 | 2002 | 134 | 0.580 |
Why?
| | Virus Diseases | 1 | 2021 | 216 | 0.570 |
Why?
| | Dimethyl Sulfoxide | 18 | 1994 | 41 | 0.570 |
Why?
| | Aerosols | 4 | 2016 | 186 | 0.560 |
Why?
| | Superoxide Dismutase | 27 | 1996 | 301 | 0.550 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 2 | 2016 | 920 | 0.550 |
Why?
| | Pre-Exposure Prophylaxis | 1 | 2021 | 246 | 0.550 |
Why?
| | Rats, Inbred Strains | 37 | 1992 | 321 | 0.530 |
Why?
| | Chemotactic Factors | 11 | 1997 | 43 | 0.530 |
Why?
| | Receptors, Cell Surface | 2 | 2015 | 377 | 0.520 |
Why?
| | Intercellular Signaling Peptides and Proteins | 6 | 2005 | 381 | 0.520 |
Why?
| | Lung Injury | 9 | 2014 | 237 | 0.520 |
Why?
| | Cytokines | 8 | 2014 | 2061 | 0.520 |
Why?
| | Oxidants | 6 | 2004 | 103 | 0.510 |
Why?
| | Respiratory Tract Infections | 1 | 2021 | 397 | 0.490 |
Why?
| | Chemotaxis, Leukocyte | 10 | 1997 | 113 | 0.490 |
Why?
| | Malathion | 1 | 2016 | 3 | 0.480 |
Why?
| | Staphylococcus aureus | 29 | 1988 | 455 | 0.480 |
Why?
| | Tetradecanoylphorbol Acetate | 20 | 1994 | 153 | 0.460 |
Why?
| | Leukocyte Elastase | 5 | 2002 | 75 | 0.450 |
Why?
| | Platelet Activating Factor | 4 | 2002 | 49 | 0.450 |
Why?
| | Antigens, Differentiation, Myelomonocytic | 1 | 2015 | 65 | 0.440 |
Why?
| | Heme Oxygenase-1 | 1 | 2015 | 74 | 0.440 |
Why?
| | Capillaries | 2 | 2015 | 124 | 0.440 |
Why?
| | Glutamine | 1 | 2015 | 109 | 0.440 |
Why?
| | Myocardial Reperfusion Injury | 9 | 1992 | 137 | 0.430 |
Why?
| | Macrophages | 24 | 1991 | 1511 | 0.430 |
Why?
| | Kidney | 11 | 1999 | 1495 | 0.420 |
Why?
| | Phagocytosis | 22 | 2007 | 299 | 0.420 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2015 | 292 | 0.410 |
Why?
| | Respiration, Artificial | 3 | 2015 | 708 | 0.410 |
Why?
| | Lung Diseases | 10 | 2007 | 787 | 0.400 |
Why?
| | Prostaglandin D2 | 1 | 2013 | 22 | 0.400 |
Why?
| | Quinacrine | 3 | 2004 | 9 | 0.400 |
Why?
| | Peroxidase | 15 | 2003 | 168 | 0.400 |
Why?
| | Nitric Oxide | 8 | 2014 | 897 | 0.390 |
Why?
| | Hydroxides | 9 | 1991 | 26 | 0.390 |
Why?
| | Neutrophil Infiltration | 1 | 2013 | 104 | 0.390 |
Why?
| | Perfusion | 22 | 2002 | 250 | 0.380 |
Why?
| | Hemorrhage | 4 | 2004 | 809 | 0.380 |
Why?
| | L-Lactate Dehydrogenase | 17 | 2013 | 115 | 0.370 |
Why?
| | Allopurinol | 11 | 2003 | 69 | 0.370 |
Why?
| | Male | 102 | 2019 | 72315 | 0.360 |
Why?
| | Myocardium | 14 | 1992 | 939 | 0.360 |
Why?
| | Antigens, CD | 1 | 2015 | 555 | 0.360 |
Why?
| | Pulmonary Artery | 13 | 1997 | 1134 | 0.350 |
Why?
| | Cell Adhesion | 15 | 2007 | 455 | 0.350 |
Why?
| | Serine Proteinase Inhibitors | 4 | 2002 | 51 | 0.350 |
Why?
| | Fruit | 1 | 2012 | 152 | 0.340 |
Why?
| | Rabbits | 29 | 1991 | 648 | 0.340 |
Why?
| | Aldehyde Oxidoreductases | 4 | 1999 | 29 | 0.340 |
Why?
| | Inflammation | 6 | 2016 | 2878 | 0.340 |
Why?
| | Tumor Necrosis Factor-alpha | 8 | 2005 | 1217 | 0.340 |
Why?
| | Vegetables | 1 | 2012 | 170 | 0.330 |
Why?
| | Pancreatic Elastase | 8 | 1993 | 55 | 0.330 |
Why?
| | Cells, Cultured | 28 | 2008 | 4154 | 0.330 |
Why?
| | Tungsten | 15 | 2003 | 30 | 0.320 |
Why?
| | Pentoxifylline | 4 | 1997 | 23 | 0.320 |
Why?
| | Pulmonary Circulation | 6 | 2005 | 430 | 0.320 |
Why?
| | Reactive Oxygen Species | 5 | 1999 | 621 | 0.310 |
Why?
| | Cattle | 18 | 2007 | 1000 | 0.310 |
Why?
| | Burns | 4 | 2019 | 377 | 0.300 |
Why?
| | Heart | 10 | 1994 | 636 | 0.300 |
Why?
| | Humans | 125 | 2021 | 144759 | 0.300 |
Why?
| | Oxidation-Reduction | 22 | 1999 | 1087 | 0.290 |
Why?
| | Deferoxamine | 3 | 2002 | 25 | 0.290 |
Why?
| | Erythrocytes | 11 | 1995 | 757 | 0.290 |
Why?
| | Phorbols | 8 | 1986 | 10 | 0.280 |
Why?
| | Soot | 1 | 2008 | 25 | 0.280 |
Why?
| | Vitamin E | 4 | 1998 | 121 | 0.280 |
Why?
| | Tissue Plasminogen Activator | 3 | 2005 | 244 | 0.280 |
Why?
| | Gulf War | 2 | 2019 | 15 | 0.270 |
Why?
| | Granulomatous Disease, Chronic | 12 | 1988 | 48 | 0.270 |
Why?
| | Biomarkers | 9 | 2019 | 4271 | 0.270 |
Why?
| | Receptors, Interleukin-1 | 4 | 1997 | 213 | 0.270 |
Why?
| | Oxygen Consumption | 19 | 1995 | 724 | 0.270 |
Why?
| | Dietary Supplements | 1 | 2012 | 576 | 0.270 |
Why?
| | Dinoprost | 2 | 2019 | 49 | 0.270 |
Why?
| | Tyrosine | 2 | 2008 | 222 | 0.260 |
Why?
| | Bacterial Infections | 7 | 1993 | 246 | 0.250 |
Why?
| | Intercellular Adhesion Molecule-1 | 3 | 2007 | 138 | 0.250 |
Why?
| | Phosphatidic Acids | 2 | 1997 | 8 | 0.250 |
Why?
| | Free Radical Scavengers | 8 | 2000 | 82 | 0.240 |
Why?
| | Shock, Septic | 3 | 2000 | 216 | 0.240 |
Why?
| | Endothelium | 10 | 1997 | 119 | 0.240 |
Why?
| | Blood Platelets | 7 | 1992 | 400 | 0.240 |
Why?
| | Leukocytes | 7 | 2007 | 295 | 0.240 |
Why?
| | Trachea | 6 | 2005 | 261 | 0.230 |
Why?
| | Phagocytes | 2 | 2003 | 81 | 0.230 |
Why?
| | Muscles | 3 | 1991 | 333 | 0.230 |
Why?
| | Particulate Matter | 1 | 2008 | 347 | 0.230 |
Why?
| | Administration, Inhalation | 5 | 2016 | 574 | 0.220 |
Why?
| | alpha-Tocopherol | 1 | 2005 | 32 | 0.220 |
Why?
| | Recombinant Proteins | 10 | 2005 | 1370 | 0.220 |
Why?
| | Leukotriene B4 | 3 | 2016 | 37 | 0.220 |
Why?
| | Krypton | 3 | 2011 | 4 | 0.220 |
Why?
| | Endotoxins | 7 | 1992 | 221 | 0.220 |
Why?
| | Obesity | 2 | 2015 | 3077 | 0.210 |
Why?
| | Tidal Volume | 2 | 2015 | 111 | 0.210 |
Why?
| | Growth Substances | 4 | 1997 | 140 | 0.210 |
Why?
| | Coronary Disease | 5 | 1991 | 383 | 0.200 |
Why?
| | Glutathione Peroxidase | 10 | 1994 | 39 | 0.200 |
Why?
| | Leukocyte Count | 8 | 2003 | 316 | 0.200 |
Why?
| | Skin | 3 | 1995 | 755 | 0.200 |
Why?
| | Nitroblue Tetrazolium | 8 | 2000 | 12 | 0.200 |
Why?
| | Mitochondria | 5 | 2008 | 984 | 0.200 |
Why?
| | Smoking | 7 | 2014 | 1472 | 0.190 |
Why?
| | Acute Kidney Injury | 3 | 1997 | 865 | 0.190 |
Why?
| | Intercellular Junctions | 1 | 2002 | 35 | 0.190 |
Why?
| | Cell Count | 4 | 2013 | 320 | 0.190 |
Why?
| | Anemia, Iron-Deficiency | 1 | 2003 | 62 | 0.190 |
Why?
| | Iron Chelating Agents | 1 | 2002 | 18 | 0.190 |
Why?
| | Postoperative Complications | 1 | 2015 | 2919 | 0.180 |
Why?
| | Permeability | 7 | 2002 | 168 | 0.180 |
Why?
| | Organ Size | 10 | 1998 | 463 | 0.180 |
Why?
| | Amitrole | 8 | 1990 | 9 | 0.180 |
Why?
| | Iron | 8 | 2002 | 359 | 0.180 |
Why?
| | Environmental Exposure | 2 | 2017 | 588 | 0.180 |
Why?
| | Dose-Response Relationship, Drug | 7 | 2016 | 2027 | 0.180 |
Why?
| | Edema | 4 | 1997 | 124 | 0.180 |
Why?
| | Neutropenia | 5 | 1997 | 155 | 0.170 |
Why?
| | Particle Size | 3 | 2016 | 411 | 0.170 |
Why?
| | Thromboxanes | 4 | 1988 | 13 | 0.170 |
Why?
| | von Willebrand Factor | 3 | 2019 | 85 | 0.170 |
Why?
| | Corneal Stroma | 1 | 2001 | 24 | 0.170 |
Why?
| | Administration, Intranasal | 1 | 2021 | 93 | 0.170 |
Why?
| | Photorefractive Keratectomy | 1 | 2001 | 21 | 0.170 |
Why?
| | Glycine | 1 | 2002 | 187 | 0.170 |
Why?
| | Sodium | 2 | 1999 | 197 | 0.160 |
Why?
| | Air Pollutants, Occupational | 1 | 2001 | 42 | 0.160 |
Why?
| | Risk Factors | 9 | 2019 | 10779 | 0.160 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 479 | 0.160 |
Why?
| | Intubation, Intratracheal | 6 | 2002 | 320 | 0.160 |
Why?
| | Chromosomes, Human, Pair 2 | 2 | 1997 | 28 | 0.160 |
Why?
| | Renal Circulation | 4 | 1997 | 75 | 0.160 |
Why?
| | Indicators and Reagents | 6 | 2000 | 106 | 0.160 |
Why?
| | Phagocyte Bactericidal Dysfunction | 5 | 1979 | 11 | 0.150 |
Why?
| | Acute Disease | 8 | 1999 | 1030 | 0.150 |
Why?
| | Nitrates | 2 | 2017 | 100 | 0.150 |
Why?
| | Kinetics | 12 | 1996 | 1627 | 0.150 |
Why?
| | Sialoglycoproteins | 2 | 1997 | 158 | 0.150 |
Why?
| | Chemokine CXCL1 | 4 | 2005 | 76 | 0.150 |
Why?
| | Saccharomyces cerevisiae | 3 | 1995 | 579 | 0.150 |
Why?
| | Alcohol Dehydrogenase | 1 | 1999 | 16 | 0.150 |
Why?
| | Physical Exertion | 1 | 2000 | 207 | 0.150 |
Why?
| | Lactoferrin | 2 | 2017 | 36 | 0.150 |
Why?
| | Triazoles | 3 | 2002 | 184 | 0.140 |
Why?
| | Luminescent Measurements | 8 | 1997 | 76 | 0.140 |
Why?
| | Interleukin-8 | 3 | 1997 | 271 | 0.140 |
Why?
| | Monocytes | 7 | 2007 | 538 | 0.140 |
Why?
| | Brain Edema | 2 | 1990 | 62 | 0.140 |
Why?
| | Kidney Tubules, Proximal | 1 | 1999 | 130 | 0.140 |
Why?
| | Alprostadil | 2 | 1997 | 29 | 0.140 |
Why?
| | Receptors, G-Protein-Coupled | 1 | 2000 | 233 | 0.140 |
Why?
| | Multiple Trauma | 1 | 1999 | 116 | 0.140 |
Why?
| | Sulfonamides | 1 | 2002 | 580 | 0.140 |
Why?
| | Female | 32 | 2019 | 78271 | 0.140 |
Why?
| | Acetylcysteine | 3 | 1995 | 139 | 0.130 |
Why?
| | Molybdenum | 1 | 1997 | 10 | 0.130 |
Why?
| | Veterans Health | 1 | 2019 | 189 | 0.130 |
Why?
| | Lung Diseases, Obstructive | 1 | 1997 | 43 | 0.130 |
Why?
| | Phospholipases A | 1 | 1997 | 98 | 0.130 |
Why?
| | Therapeutic Irrigation | 7 | 1997 | 69 | 0.130 |
Why?
| | Chronic Disease | 3 | 2014 | 1813 | 0.130 |
Why?
| | Polyethylene Glycols | 5 | 1990 | 654 | 0.120 |
Why?
| | Neutrophil Activation | 1 | 1997 | 85 | 0.120 |
Why?
| | Chromatography, Affinity | 1 | 1996 | 85 | 0.120 |
Why?
| | Magnetic Resonance Spectroscopy | 2 | 2011 | 630 | 0.120 |
Why?
| | Receptors, Tumor Necrosis Factor | 1 | 1996 | 163 | 0.120 |
Why?
| | Sepsis | 2 | 2000 | 640 | 0.120 |
Why?
| | DNA Damage | 1 | 1999 | 430 | 0.120 |
Why?
| | Fatty Acids, Unsaturated | 1 | 1996 | 98 | 0.120 |
Why?
| | Fatty Acids, Nonesterified | 1 | 1996 | 158 | 0.110 |
Why?
| | Carbonates | 1 | 1995 | 11 | 0.110 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2017 | 851 | 0.110 |
Why?
| | One-Lung Ventilation | 1 | 2015 | 6 | 0.110 |
Why?
| | Menstruation | 2 | 1986 | 42 | 0.110 |
Why?
| | Pulmonary Surfactants | 3 | 2007 | 102 | 0.110 |
Why?
| | Mice, Inbred Strains | 1 | 2016 | 397 | 0.110 |
Why?
| | Adjuvants, Immunologic | 1 | 1997 | 245 | 0.110 |
Why?
| | Ethanol | 2 | 1999 | 627 | 0.110 |
Why?
| | Vitamin E Deficiency | 1 | 1995 | 42 | 0.110 |
Why?
| | Sodium Bicarbonate | 1 | 1995 | 47 | 0.110 |
Why?
| | Interleukin-10 | 1 | 1997 | 309 | 0.110 |
Why?
| | Serum Albumin | 4 | 1994 | 147 | 0.110 |
Why?
| | Muscle, Smooth, Vascular | 2 | 1997 | 452 | 0.110 |
Why?
| | Vinblastine | 6 | 1997 | 75 | 0.110 |
Why?
| | Hypoxia | 3 | 2015 | 1199 | 0.110 |
Why?
| | Predictive Value of Tests | 5 | 2019 | 2115 | 0.110 |
Why?
| | Glutathione Disulfide | 5 | 1994 | 32 | 0.110 |
Why?
| | Oligonucleotides | 1 | 1995 | 151 | 0.110 |
Why?
| | Arachidonate 5-Lipoxygenase | 1 | 1994 | 36 | 0.110 |
Why?
| | Carbon Dioxide | 2 | 1995 | 242 | 0.110 |
Why?
| | Vasoconstriction | 3 | 1988 | 217 | 0.110 |
Why?
| | Reperfusion | 2 | 1992 | 54 | 0.100 |
Why?
| | Positive-Pressure Respiration | 1 | 2015 | 112 | 0.100 |
Why?
| | Cell Movement | 6 | 1996 | 965 | 0.100 |
Why?
| | Case-Control Studies | 2 | 2019 | 3604 | 0.100 |
Why?
| | Insufflation | 1 | 2013 | 13 | 0.100 |
Why?
| | Granulocytes | 3 | 1982 | 80 | 0.100 |
Why?
| | Critical Care | 1 | 2000 | 695 | 0.100 |
Why?
| | Liver | 2 | 2000 | 1887 | 0.100 |
Why?
| | Oligopeptides | 2 | 1992 | 269 | 0.100 |
Why?
| | Liposomes | 3 | 1997 | 250 | 0.100 |
Why?
| | Molecular Sequence Data | 6 | 1999 | 2930 | 0.100 |
Why?
| | Smoke | 2 | 2007 | 148 | 0.100 |
Why?
| | Hemolysis | 2 | 1993 | 243 | 0.100 |
Why?
| | Purines | 4 | 2002 | 187 | 0.100 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2925 | 0.100 |
Why?
| | Hydroxyl Radical | 7 | 1991 | 95 | 0.090 |
Why?
| | Hypertension, Pulmonary | 5 | 1987 | 1980 | 0.090 |
Why?
| | Perioperative Care | 1 | 2015 | 231 | 0.090 |
Why?
| | Serpins | 1 | 1992 | 28 | 0.090 |
Why?
| | Sulfhydryl Compounds | 3 | 1992 | 189 | 0.090 |
Why?
| | Glucose Oxidase | 3 | 1987 | 25 | 0.090 |
Why?
| | Microscopy, Electron | 6 | 2000 | 415 | 0.090 |
Why?
| | Pleural Effusion | 4 | 1992 | 60 | 0.090 |
Why?
| | Tetrazolium Salts | 5 | 1991 | 18 | 0.090 |
Why?
| | Opsonin Proteins | 7 | 1988 | 19 | 0.090 |
Why?
| | Disease Susceptibility | 1 | 2014 | 348 | 0.090 |
Why?
| | Acute Lung Injury | 1 | 2015 | 303 | 0.090 |
Why?
| | Respiration | 3 | 2001 | 206 | 0.090 |
Why?
| | Complement C2 | 4 | 1979 | 8 | 0.090 |
Why?
| | Inhalation | 1 | 2011 | 29 | 0.090 |
Why?
| | Escherichia coli | 4 | 1988 | 854 | 0.090 |
Why?
| | Melanocytes | 1 | 1991 | 65 | 0.080 |
Why?
| | Cell Hypoxia | 1 | 1992 | 247 | 0.080 |
Why?
| | N-Formylmethionine Leucyl-Phenylalanine | 3 | 1997 | 39 | 0.080 |
Why?
| | Leukocytes, Mononuclear | 2 | 1991 | 573 | 0.080 |
Why?
| | Muramidase | 3 | 1988 | 67 | 0.080 |
Why?
| | Oxidoreductases | 1 | 1991 | 96 | 0.080 |
Why?
| | Azepines | 2 | 2002 | 107 | 0.080 |
Why?
| | Salmonella typhimurium | 2 | 1991 | 190 | 0.080 |
Why?
| | Phosphorylation | 1 | 2015 | 1732 | 0.080 |
Why?
| | Electron Spin Resonance Spectroscopy | 2 | 2008 | 97 | 0.080 |
Why?
| | Xenon Isotopes | 2 | 2007 | 7 | 0.080 |
Why?
| | Base Sequence | 5 | 1999 | 2190 | 0.080 |
Why?
| | Brain | 3 | 1992 | 2933 | 0.080 |
Why?
| | Diterpenes | 3 | 1975 | 26 | 0.080 |
Why?
| | Shock | 1 | 1991 | 108 | 0.080 |
Why?
| | Paraquat | 1 | 1990 | 13 | 0.080 |
Why?
| | Riboflavin | 1 | 1990 | 15 | 0.080 |
Why?
| | Keratinocytes | 1 | 1991 | 248 | 0.080 |
Why?
| | Glycoconjugates | 1 | 1990 | 7 | 0.080 |
Why?
| | Adult | 22 | 2019 | 40449 | 0.080 |
Why?
| | Blood Cells | 1 | 1990 | 37 | 0.080 |
Why?
| | Middle Aged | 10 | 2019 | 35875 | 0.080 |
Why?
| | Diabetes Mellitus | 2 | 2014 | 1098 | 0.080 |
Why?
| | Arachidonic Acids | 1 | 1990 | 43 | 0.080 |
Why?
| | Factor VII | 1 | 1989 | 25 | 0.080 |
Why?
| | Hyperbaric Oxygenation | 2 | 1987 | 39 | 0.080 |
Why?
| | Fibroblasts | 3 | 1991 | 1034 | 0.080 |
Why?
| | Reference Values | 4 | 1997 | 797 | 0.080 |
Why?
| | Aldehyde Oxidase | 3 | 1999 | 3 | 0.080 |
Why?
| | Substrate Specificity | 3 | 1996 | 388 | 0.070 |
Why?
| | Intestines | 1 | 1992 | 358 | 0.070 |
Why?
| | Alkaline Phosphatase | 3 | 1986 | 145 | 0.070 |
Why?
| | Mycobacterium bovis | 3 | 1985 | 15 | 0.070 |
Why?
| | Biological Factors | 1 | 1989 | 39 | 0.070 |
Why?
| | Krypton Radioisotopes | 1 | 2008 | 1 | 0.070 |
Why?
| | Metals | 1 | 1990 | 142 | 0.070 |
Why?
| | RNA | 1 | 1995 | 940 | 0.070 |
Why?
| | Myocardial Reperfusion | 4 | 1994 | 59 | 0.070 |
Why?
| | Superantigens | 1 | 1988 | 70 | 0.070 |
Why?
| | Enterotoxins | 1 | 1988 | 89 | 0.070 |
Why?
| | Antigens | 2 | 1989 | 347 | 0.070 |
Why?
| | Thromboxane B2 | 2 | 1988 | 23 | 0.070 |
Why?
| | Blood Pressure | 6 | 1995 | 1769 | 0.070 |
Why?
| | Time Factors | 10 | 2000 | 7173 | 0.070 |
Why?
| | Amino Acid Sequence | 3 | 1999 | 2155 | 0.070 |
Why?
| | Nitroarginine | 2 | 1999 | 57 | 0.070 |
Why?
| | RNA, Messenger | 4 | 2005 | 2832 | 0.070 |
Why?
| | Bacterial Toxins | 1 | 1988 | 109 | 0.070 |
Why?
| | Nitroprusside | 2 | 1999 | 72 | 0.070 |
Why?
| | Exercise | 1 | 2000 | 2201 | 0.070 |
Why?
| | Proteins | 5 | 1997 | 1021 | 0.070 |
Why?
| | Mice | 5 | 2016 | 18339 | 0.070 |
Why?
| | Lymphocyte Function-Associated Antigen-1 | 1 | 2007 | 27 | 0.070 |
Why?
| | Integrin alpha4beta1 | 1 | 2007 | 8 | 0.070 |
Why?
| | Inhalation Exposure | 1 | 2008 | 115 | 0.070 |
Why?
| | Bronchoalveolar Lavage | 2 | 1998 | 89 | 0.070 |
Why?
| | Glomerular Filtration Rate | 4 | 1997 | 760 | 0.070 |
Why?
| | Epithelial Cells | 2 | 2007 | 1125 | 0.060 |
Why?
| | Creatine Kinase | 3 | 2000 | 72 | 0.060 |
Why?
| | Phospholipids | 2 | 2000 | 213 | 0.060 |
Why?
| | Image Enhancement | 1 | 2008 | 199 | 0.060 |
Why?
| | Nylons | 3 | 1984 | 23 | 0.060 |
Why?
| | Zymosan | 5 | 1990 | 39 | 0.060 |
Why?
| | Disease | 2 | 2017 | 98 | 0.060 |
Why?
| | Glucosephosphate Dehydrogenase | 3 | 1994 | 69 | 0.060 |
Why?
| | Alcoholism | 1 | 2014 | 817 | 0.060 |
Why?
| | Thromboxane A2 | 2 | 1983 | 10 | 0.060 |
Why?
| | Cell Separation | 2 | 1997 | 307 | 0.060 |
Why?
| | Complement Activation | 3 | 1995 | 411 | 0.060 |
Why?
| | Ischemic Attack, Transient | 1 | 1987 | 71 | 0.060 |
Why?
| | Cell Division | 2 | 1985 | 766 | 0.060 |
Why?
| | DNA, Complementary | 2 | 1999 | 276 | 0.060 |
Why?
| | Arginine | 2 | 1998 | 262 | 0.060 |
Why?
| | NF-kappa B | 2 | 2002 | 661 | 0.060 |
Why?
| | Breast Neoplasms | 1 | 1999 | 2452 | 0.060 |
Why?
| | Cytochrome c Group | 3 | 1994 | 43 | 0.060 |
Why?
| | Sequence Homology, Amino Acid | 2 | 1999 | 396 | 0.060 |
Why?
| | Menstrual Cycle | 1 | 1986 | 140 | 0.060 |
Why?
| | Polymerase Chain Reaction | 3 | 1999 | 1054 | 0.060 |
Why?
| | Peptidyl-Dipeptidase A | 2 | 1985 | 56 | 0.060 |
Why?
| | Cloning, Molecular | 2 | 1999 | 540 | 0.060 |
Why?
| | HEPES | 1 | 1985 | 2 | 0.060 |
Why?
| | Contrast Media | 1 | 2008 | 488 | 0.060 |
Why?
| | Magnetic Resonance Imaging | 2 | 2008 | 3863 | 0.060 |
Why?
| | Glycoproteins | 1 | 1987 | 355 | 0.060 |
Why?
| | Agranulocytosis | 2 | 1982 | 30 | 0.060 |
Why?
| | Drug Carriers | 2 | 1997 | 130 | 0.050 |
Why?
| | Staphylococcal Infections | 2 | 1986 | 388 | 0.050 |
Why?
| | Isotopes | 3 | 2011 | 34 | 0.050 |
Why?
| | Cerebrovascular Circulation | 1 | 1987 | 280 | 0.050 |
Why?
| | Peroxidases | 2 | 1991 | 29 | 0.050 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 2 | 1997 | 253 | 0.050 |
Why?
| | Spectrophotometry, Ultraviolet | 2 | 2017 | 85 | 0.050 |
Why?
| | Models, Biological | 4 | 2011 | 1821 | 0.050 |
Why?
| | Mesocricetus | 2 | 1995 | 46 | 0.050 |
Why?
| | Mannitol | 4 | 1991 | 40 | 0.050 |
Why?
| | Enzyme Induction | 1 | 2003 | 88 | 0.050 |
Why?
| | Tuberculoma | 1 | 1983 | 2 | 0.050 |
Why?
| | Iron, Dietary | 1 | 2003 | 23 | 0.050 |
Why?
| | Cricetinae | 2 | 1995 | 303 | 0.050 |
Why?
| | Kidney Diseases | 1 | 1987 | 427 | 0.050 |
Why?
| | Aspirin | 2 | 1984 | 399 | 0.050 |
Why?
| | Genetic Therapy | 1 | 2005 | 313 | 0.050 |
Why?
| | Vasodilator Agents | 2 | 1999 | 331 | 0.050 |
Why?
| | Lidocaine | 3 | 1987 | 54 | 0.050 |
Why?
| | Osmolar Concentration | 3 | 1994 | 167 | 0.050 |
Why?
| | Methylprednisolone | 1 | 1983 | 64 | 0.050 |
Why?
| | Carrier Proteins | 2 | 1997 | 737 | 0.050 |
Why?
| | Thiobarbituric Acid Reactive Substances | 1 | 2002 | 29 | 0.050 |
Why?
| | Tetracaine | 2 | 1979 | 5 | 0.050 |
Why?
| | Hematocrit | 3 | 1992 | 108 | 0.050 |
Why?
| | Blastomycosis | 2 | 1981 | 11 | 0.050 |
Why?
| | Cryptococcus neoformans | 1 | 1982 | 21 | 0.050 |
Why?
| | Leukemia, Myeloid | 2 | 1979 | 48 | 0.050 |
Why?
| | Cryptococcus | 1 | 1982 | 16 | 0.050 |
Why?
| | Piperazines | 1 | 1985 | 381 | 0.050 |
Why?
| | Chediak-Higashi Syndrome | 2 | 1979 | 7 | 0.050 |
Why?
| | Pyelonephritis | 1 | 1982 | 11 | 0.050 |
Why?
| | Xanthogranuloma, Juvenile | 1 | 1982 | 6 | 0.050 |
Why?
| | Tuberculosis, Pulmonary | 1 | 1983 | 131 | 0.050 |
Why?
| | Drug Delivery Systems | 1 | 2005 | 380 | 0.040 |
Why?
| | Chromatography, Gas | 3 | 1988 | 32 | 0.040 |
Why?
| | Nitrogen Mustard Compounds | 1 | 1981 | 9 | 0.040 |
Why?
| | Hydrogen-Ion Concentration | 3 | 1995 | 561 | 0.040 |
Why?
| | Disease Models, Animal | 3 | 1998 | 4557 | 0.040 |
Why?
| | Environmental Pollution | 1 | 2001 | 21 | 0.040 |
Why?
| | Complement Pathway, Alternative | 1 | 1982 | 122 | 0.040 |
Why?
| | Volatilization | 1 | 2001 | 52 | 0.040 |
Why?
| | DNA, Superhelical | 1 | 1981 | 12 | 0.040 |
Why?
| | Signal Transduction | 1 | 1995 | 5226 | 0.040 |
Why?
| | Lasers, Excimer | 1 | 2001 | 30 | 0.040 |
Why?
| | 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid | 2 | 1992 | 6 | 0.040 |
Why?
| | 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid | 2 | 1992 | 9 | 0.040 |
Why?
| | Microscopy, Electron, Scanning | 4 | 1990 | 199 | 0.040 |
Why?
| | Platelet Membrane Glycoproteins | 1 | 2000 | 35 | 0.040 |
Why?
| | Malondialdehyde | 1 | 2000 | 30 | 0.040 |
Why?
| | Mycoses | 1 | 1981 | 88 | 0.040 |
Why?
| | Urea | 3 | 1990 | 84 | 0.040 |
Why?
| | DNA Primers | 2 | 1999 | 512 | 0.040 |
Why?
| | Glucose | 8 | 1980 | 1047 | 0.040 |
Why?
| | Prospective Studies | 3 | 2019 | 7990 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 2000 | 85 | 0.040 |
Why?
| | Sensitivity and Specificity | 2 | 1997 | 1985 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2003 | 784 | 0.040 |
Why?
| | Methylurea Compounds | 2 | 1994 | 7 | 0.040 |
Why?
| | Ethylenes | 1 | 1979 | 17 | 0.040 |
Why?
| | 6-Aminonicotinamide | 2 | 1990 | 2 | 0.040 |
Why?
| | Glutathione Reductase | 2 | 1990 | 25 | 0.040 |
Why?
| | DNA, Single-Stranded | 1 | 1981 | 119 | 0.040 |
Why?
| | Chemical Phenomena | 2 | 1995 | 81 | 0.040 |
Why?
| | Organ Preservation | 2 | 1991 | 130 | 0.040 |
Why?
| | Coronary Circulation | 3 | 1991 | 136 | 0.040 |
Why?
| | Premedication | 3 | 1985 | 42 | 0.040 |
Why?
| | Biological Transport | 2 | 1999 | 417 | 0.040 |
Why?
| | Chemotaxis | 2 | 1979 | 122 | 0.040 |
Why?
| | Bradykinin | 1 | 1999 | 48 | 0.040 |
Why?
| | Radioimmunoassay | 2 | 1997 | 165 | 0.040 |
Why?
| | Hot Temperature | 3 | 1994 | 407 | 0.040 |
Why?
| | Cyclic GMP | 1 | 1999 | 92 | 0.040 |
Why?
| | Chromosome Mapping | 2 | 1997 | 510 | 0.040 |
Why?
| | Sodium-Potassium-Exchanging ATPase | 1 | 1999 | 56 | 0.040 |
Why?
| | Rats, Wistar | 1 | 2000 | 451 | 0.040 |
Why?
| | Albumins | 3 | 1991 | 118 | 0.040 |
Why?
| | DNA, Viral | 1 | 1981 | 358 | 0.040 |
Why?
| | Myocardial Contraction | 3 | 1989 | 298 | 0.040 |
Why?
| | Instillation, Drug | 1 | 1998 | 9 | 0.040 |
Why?
| | Culture Techniques | 2 | 1992 | 67 | 0.040 |
Why?
| | Hyperoxia | 1 | 1999 | 99 | 0.040 |
Why?
| | Gerbillinae | 2 | 1990 | 72 | 0.030 |
Why?
| | Anesthetics, Local | 1 | 1979 | 100 | 0.030 |
Why?
| | Injections, Intraperitoneal | 1 | 1998 | 116 | 0.030 |
Why?
| | Coculture Techniques | 1 | 1999 | 246 | 0.030 |
Why?
| | Acetylcholine | 1 | 1999 | 204 | 0.030 |
Why?
| | Pulmonary Ventilation | 2 | 2011 | 83 | 0.030 |
Why?
| | Myocardial Infarction | 3 | 1991 | 1209 | 0.030 |
Why?
| | Levamisole | 1 | 1977 | 21 | 0.030 |
Why?
| | Cloning, Organism | 1 | 1997 | 7 | 0.030 |
Why?
| | Linoleic Acid | 1 | 1997 | 44 | 0.030 |
Why?
| | Oleic Acid | 1 | 1997 | 42 | 0.030 |
Why?
| | Muscle Contraction | 2 | 1990 | 429 | 0.030 |
Why?
| | Phospholipases A2 | 1 | 1997 | 79 | 0.030 |
Why?
| | Spectrometry, Fluorescence | 1 | 2017 | 168 | 0.030 |
Why?
| | Electron Transport | 2 | 1995 | 118 | 0.030 |
Why?
| | Amino Acid Chloromethyl Ketones | 1 | 1997 | 24 | 0.030 |
Why?
| | Methane | 3 | 1983 | 51 | 0.030 |
Why?
| | Absorption | 1 | 1997 | 60 | 0.030 |
Why?
| | NADP | 2 | 1988 | 55 | 0.030 |
Why?
| | Tumor Necrosis Factor Decoy Receptors | 1 | 1996 | 8 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 2 | 1990 | 594 | 0.030 |
Why?
| | Benzamidines | 1 | 1996 | 3 | 0.030 |
Why?
| | Complement System Proteins | 2 | 1977 | 316 | 0.030 |
Why?
| | Isoelectric Point | 1 | 1996 | 23 | 0.030 |
Why?
| | Injury Severity Score | 1 | 1999 | 600 | 0.030 |
Why?
| | Xanthines | 1 | 1996 | 22 | 0.030 |
Why?
| | Immunoassay | 1 | 1997 | 109 | 0.030 |
Why?
| | Receptors, Tumor Necrosis Factor, Type I | 1 | 1996 | 81 | 0.030 |
Why?
| | Hydrolysis | 1 | 1997 | 199 | 0.030 |
Why?
| | Sepharose | 1 | 1996 | 32 | 0.030 |
Why?
| | Blood Proteins | 1 | 1978 | 249 | 0.030 |
Why?
| | Drug Administration Schedule | 1 | 1998 | 779 | 0.030 |
Why?
| | Endocarditis, Bacterial | 1 | 1976 | 44 | 0.030 |
Why?
| | Sodium Chloride | 2 | 1990 | 141 | 0.030 |
Why?
| | Interleukin-4 | 1 | 1997 | 206 | 0.030 |
Why?
| | HIV Infections | 1 | 1992 | 3154 | 0.030 |
Why?
| | Ambulatory Care | 1 | 2001 | 600 | 0.030 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1519 | 0.030 |
Why?
| | Diet | 4 | 1995 | 1273 | 0.030 |
Why?
| | Cathepsin G | 1 | 1995 | 4 | 0.030 |
Why?
| | Chemistry, Physical | 1 | 1995 | 39 | 0.030 |
Why?
| | Cathepsins | 1 | 1995 | 24 | 0.030 |
Why?
| | Injections | 1 | 1996 | 196 | 0.030 |
Why?
| | Hydrochloric Acid | 1 | 1995 | 9 | 0.030 |
Why?
| | Adenine | 2 | 1997 | 339 | 0.030 |
Why?
| | Aged | 5 | 2019 | 25913 | 0.030 |
Why?
| | Isoenzymes | 1 | 1996 | 299 | 0.030 |
Why?
| | Cross Reactions | 1 | 1995 | 130 | 0.030 |
Why?
| | Sex Chromosomes | 1 | 1975 | 53 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2003 | 2050 | 0.030 |
Why?
| | Single-Blind Method | 1 | 1996 | 312 | 0.030 |
Why?
| | Injections, Spinal | 1 | 1995 | 120 | 0.030 |
Why?
| | Erythrocyte Indices | 1 | 1995 | 33 | 0.030 |
Why?
| | Factor VIII | 2 | 1993 | 104 | 0.030 |
Why?
| | Serine Endopeptidases | 1 | 1995 | 128 | 0.030 |
Why?
| | Apoptosis | 1 | 2003 | 2430 | 0.030 |
Why?
| | Chlorobenzenes | 1 | 1994 | 19 | 0.030 |
Why?
| | Tuberculosis, Pleural | 2 | 1985 | 7 | 0.030 |
Why?
| | ROC Curve | 1 | 1997 | 614 | 0.030 |
Why?
| | Uteroglobin | 1 | 2014 | 30 | 0.030 |
Why?
| | Acyltransferases | 1 | 1995 | 78 | 0.030 |
Why?
| | Cytosol | 1 | 1995 | 227 | 0.030 |
Why?
| | Leukotriene Antagonists | 1 | 1994 | 23 | 0.030 |
Why?
| | Croton Oil | 1 | 1974 | 3 | 0.030 |
Why?
| | Hydroxyurea | 1 | 1994 | 34 | 0.030 |
Why?
| | Lipoxygenase Inhibitors | 1 | 1994 | 34 | 0.030 |
Why?
| | C-Reactive Protein | 1 | 1997 | 416 | 0.030 |
Why?
| | Drug Tolerance | 1 | 1994 | 100 | 0.030 |
Why?
| | Enzyme Activation | 3 | 1991 | 766 | 0.030 |
Why?
| | Ficoll | 1 | 1994 | 4 | 0.030 |
Why?
| | Nitrites | 1 | 2014 | 89 | 0.030 |
Why?
| | Adolescent | 8 | 1999 | 22428 | 0.030 |
Why?
| | Anions | 3 | 1995 | 31 | 0.030 |
Why?
| | Serum Albumin, Radio-Iodinated | 1 | 1994 | 2 | 0.030 |
Why?
| | Methods | 2 | 1984 | 69 | 0.030 |
Why?
| | Breath Tests | 1 | 1994 | 79 | 0.030 |
Why?
| | Restriction Mapping | 1 | 1993 | 80 | 0.030 |
Why?
| | Drug Combinations | 1 | 1995 | 390 | 0.030 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1995 | 99 | 0.030 |
Why?
| | United States | 1 | 2011 | 15966 | 0.030 |
Why?
| | Pressure | 2 | 1986 | 225 | 0.030 |
Why?
| | Dogs | 6 | 1991 | 437 | 0.030 |
Why?
| | Diptera | 1 | 1993 | 31 | 0.020 |
Why?
| | Stomach | 1 | 1994 | 109 | 0.020 |
Why?
| | Genes | 1 | 1993 | 226 | 0.020 |
Why?
| | Clinical Enzyme Tests | 1 | 1993 | 9 | 0.020 |
Why?
| | Haploidy | 1 | 1993 | 28 | 0.020 |
Why?
| | Sequence Alignment | 1 | 1993 | 366 | 0.020 |
Why?
| | Epoprostenol | 2 | 1991 | 131 | 0.020 |
Why?
| | Myocardial Ischemia | 1 | 1994 | 285 | 0.020 |
Why?
| | Platelet Count | 2 | 1984 | 96 | 0.020 |
Why?
| | Shock, Hemorrhagic | 1 | 1995 | 201 | 0.020 |
Why?
| | Hemoglobins | 1 | 1995 | 384 | 0.020 |
Why?
| | Chromium | 1 | 1992 | 17 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 1992 | 200 | 0.020 |
Why?
| | Drosophila | 1 | 1993 | 166 | 0.020 |
Why?
| | Gene Expression | 2 | 1995 | 1490 | 0.020 |
Why?
| | Biomechanical Phenomena | 2 | 1987 | 842 | 0.020 |
Why?
| | Glucosephosphates | 1 | 1991 | 3 | 0.020 |
Why?
| | Glucose-6-Phosphate | 1 | 1991 | 6 | 0.020 |
Why?
| | Membrane Proteins | 1 | 1978 | 1166 | 0.020 |
Why?
| | Elapid Venoms | 1 | 1991 | 13 | 0.020 |
Why?
| | Survival Rate | 1 | 1997 | 2089 | 0.020 |
Why?
| | Mechlorethamine | 2 | 1982 | 53 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2019 | 3409 | 0.020 |
Why?
| | Ethylmaleimide | 2 | 1989 | 18 | 0.020 |
Why?
| | Double-Blind Method | 1 | 1996 | 2029 | 0.020 |
Why?
| | Disease Progression | 1 | 1999 | 2847 | 0.020 |
Why?
| | Pentetic Acid | 1 | 1991 | 11 | 0.020 |
Why?
| | Immunoglobulin G | 1 | 1995 | 893 | 0.020 |
Why?
| | Sodium Azide | 1 | 1990 | 6 | 0.020 |
Why?
| | Ventricular Function | 1 | 1991 | 57 | 0.020 |
Why?
| | Formaldehyde | 1 | 1991 | 66 | 0.020 |
Why?
| | Azides | 1 | 1990 | 47 | 0.020 |
Why?
| | Alcohols | 3 | 1975 | 28 | 0.020 |
Why?
| | Acquired Immunodeficiency Syndrome | 1 | 1992 | 235 | 0.020 |
Why?
| | Indoles | 1 | 1994 | 501 | 0.020 |
Why?
| | Edetic Acid | 1 | 1990 | 47 | 0.020 |
Why?
| | Arteries | 2 | 1988 | 259 | 0.020 |
Why?
| | Muscle, Skeletal | 1 | 2000 | 1795 | 0.020 |
Why?
| | Guinea Pigs | 1 | 1990 | 159 | 0.020 |
Why?
| | Brain Chemistry | 1 | 1990 | 116 | 0.020 |
Why?
| | Organ Culture Techniques | 1 | 1990 | 154 | 0.020 |
Why?
| | Body Weight | 1 | 1994 | 976 | 0.020 |
Why?
| | Enzyme Stability | 2 | 2005 | 73 | 0.020 |
Why?
| | Methionine | 1 | 1990 | 162 | 0.020 |
Why?
| | Arthroplasty, Replacement, Knee | 1 | 2014 | 370 | 0.020 |
Why?
| | Analysis of Variance | 1 | 1992 | 1306 | 0.020 |
Why?
| | Heart Arrest, Induced | 1 | 1989 | 34 | 0.020 |
Why?
| | Cell Survival | 2 | 1990 | 1098 | 0.020 |
Why?
| | Catalysis | 1 | 1990 | 322 | 0.020 |
Why?
| | Carmustine | 1 | 1988 | 52 | 0.020 |
Why?
| | Streptococcus pneumoniae | 2 | 1981 | 177 | 0.020 |
Why?
| | Epithelium | 1 | 1990 | 314 | 0.020 |
Why?
| | Pentose Phosphate Pathway | 1 | 1988 | 55 | 0.020 |
Why?
| | Biological Assay | 2 | 1981 | 128 | 0.020 |
Why?
| | Campylobacter fetus | 1 | 1988 | 1 | 0.020 |
Why?
| | Protamines | 1 | 1988 | 8 | 0.020 |
Why?
| | Interleukin-2 | 1 | 1989 | 437 | 0.020 |
Why?
| | Campylobacter Infections | 1 | 1988 | 18 | 0.020 |
Why?
| | Temperature | 2 | 1983 | 679 | 0.020 |
Why?
| | Papaverine | 1 | 1987 | 2 | 0.020 |
Why?
| | Prognosis | 1 | 1997 | 4282 | 0.020 |
Why?
| | Helium | 1 | 2007 | 6 | 0.020 |
Why?
| | Antimycin A | 2 | 1995 | 14 | 0.020 |
Why?
| | Microbial Collagenase | 1 | 1987 | 8 | 0.020 |
Why?
| | Organ Specificity | 1 | 1988 | 312 | 0.020 |
Why?
| | Wounds and Injuries | 1 | 1996 | 956 | 0.020 |
Why?
| | Tissue Fixation | 1 | 2007 | 36 | 0.020 |
Why?
| | Vascular Cell Adhesion Molecule-1 | 1 | 2007 | 40 | 0.020 |
Why?
| | Constriction | 1 | 1987 | 47 | 0.020 |
Why?
| | Hemiplegia | 1 | 1987 | 20 | 0.020 |
Why?
| | Nicotine | 1 | 1990 | 331 | 0.020 |
Why?
| | Membranes | 1 | 1987 | 13 | 0.020 |
Why?
| | Heart Ventricles | 2 | 1989 | 760 | 0.020 |
Why?
| | Fatty Acids | 3 | 1975 | 450 | 0.020 |
Why?
| | Complement C3 | 1 | 1988 | 191 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1986 | 5408 | 0.020 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2007 | 331 | 0.020 |
Why?
| | Anti-Arrhythmia Agents | 1 | 1987 | 142 | 0.020 |
Why?
| | Phantoms, Imaging | 1 | 2007 | 158 | 0.020 |
Why?
| | Cell Membrane | 3 | 1978 | 706 | 0.020 |
Why?
| | Regional Blood Flow | 1 | 1988 | 514 | 0.020 |
Why?
| | Brain Ischemia | 1 | 1990 | 358 | 0.010 |
Why?
| | Carboxypeptidases | 1 | 1985 | 12 | 0.010 |
Why?
| | Drug Synergism | 1 | 1986 | 357 | 0.010 |
Why?
| | Carotid Arteries | 1 | 1987 | 207 | 0.010 |
Why?
| | Tissue Adhesions | 1 | 1985 | 34 | 0.010 |
Why?
| | Surface Properties | 1 | 2007 | 410 | 0.010 |
Why?
| | Chemistry, Pharmaceutical | 1 | 2005 | 109 | 0.010 |
Why?
| | Sneezing | 1 | 1985 | 1 | 0.010 |
Why?
| | Granuloma | 1 | 1985 | 96 | 0.010 |
Why?
| | Lipid Peroxides | 1 | 1985 | 10 | 0.010 |
Why?
| | Respiratory Physiological Phenomena | 1 | 1985 | 35 | 0.010 |
Why?
| | Sheep | 2 | 1988 | 880 | 0.010 |
Why?
| | Blotting, Western | 1 | 2007 | 1187 | 0.010 |
Why?
| | Adenosine Triphosphate | 1 | 1987 | 498 | 0.010 |
Why?
| | Cell Communication | 1 | 1987 | 324 | 0.010 |
Why?
| | Rheology | 1 | 1985 | 94 | 0.010 |
Why?
| | Hemodynamics | 4 | 1991 | 1121 | 0.010 |
Why?
| | Mucous Membrane | 1 | 1985 | 127 | 0.010 |
Why?
| | Pleurisy | 1 | 1983 | 6 | 0.010 |
Why?
| | Cyanamide | 1 | 1983 | 1 | 0.010 |
Why?
| | Singlet Oxygen | 1 | 1984 | 18 | 0.010 |
Why?
| | Cough | 1 | 1985 | 124 | 0.010 |
Why?
| | Radiation Injuries, Experimental | 1 | 1983 | 20 | 0.010 |
Why?
| | Behavior, Animal | 1 | 1987 | 519 | 0.010 |
Why?
| | Respiratory System | 1 | 1985 | 149 | 0.010 |
Why?
| | Dietary Proteins | 1 | 1985 | 136 | 0.010 |
Why?
| | Blood Glucose | 4 | 1983 | 2327 | 0.010 |
Why?
| | Immunization | 1 | 1985 | 374 | 0.010 |
Why?
| | Molecular Weight | 1 | 1983 | 327 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2007 | 1716 | 0.010 |
Why?
| | Prostanoic Acids | 1 | 1983 | 1 | 0.010 |
Why?
| | BCG Vaccine | 1 | 1983 | 27 | 0.010 |
Why?
| | Bacteria | 2 | 1981 | 889 | 0.010 |
Why?
| | Immunity, Cellular | 1 | 1985 | 272 | 0.010 |
Why?
| | Mammals | 1 | 1985 | 293 | 0.010 |
Why?
| | Macrophage Activation | 1 | 1984 | 193 | 0.010 |
Why?
| | Fibrinolytic Agents | 1 | 2005 | 291 | 0.010 |
Why?
| | Mice, Inbred BALB C | 2 | 1996 | 1253 | 0.010 |
Why?
| | Dietary Fats | 1 | 1985 | 314 | 0.010 |
Why?
| | Mycobacterium tuberculosis | 1 | 1986 | 334 | 0.010 |
Why?
| | Blood Physiological Phenomena | 1 | 1982 | 12 | 0.010 |
Why?
| | Cytological Techniques | 1 | 1982 | 28 | 0.010 |
Why?
| | Serum Albumin, Bovine | 1 | 1982 | 62 | 0.010 |
Why?
| | Pulmonary Fibrosis | 1 | 1986 | 395 | 0.010 |
Why?
| | Stimulation, Chemical | 2 | 1978 | 53 | 0.010 |
Why?
| | Leukocyte Adherence Inhibition Test | 1 | 1981 | 1 | 0.010 |
Why?
| | Pulmonary Veins | 1 | 1982 | 105 | 0.010 |
Why?
| | Histoplasmosis | 1 | 1981 | 15 | 0.010 |
Why?
| | Imidazoles | 1 | 1983 | 254 | 0.010 |
Why?
| | Vacuoles | 2 | 1978 | 38 | 0.010 |
Why?
| | Bacterial Vaccines | 1 | 1981 | 63 | 0.010 |
Why?
| | Skin Tests | 1 | 1981 | 94 | 0.010 |
Why?
| | Feasibility Studies | 1 | 2005 | 1095 | 0.010 |
Why?
| | Enterococcus faecalis | 2 | 1979 | 28 | 0.010 |
Why?
| | Protein Biosynthesis | 1 | 1983 | 458 | 0.010 |
Why?
| | Cytotoxicity, Immunologic | 1 | 1981 | 223 | 0.010 |
Why?
| | Ethane | 1 | 1979 | 2 | 0.010 |
Why?
| | Hexosephosphates | 1 | 1979 | 2 | 0.010 |
Why?
| | Keto Acids | 1 | 1979 | 13 | 0.010 |
Why?
| | Anti-Inflammatory Agents | 1 | 1983 | 474 | 0.010 |
Why?
| | Bacteriolysis | 1 | 1979 | 10 | 0.010 |
Why?
| | Ferrous Compounds | 1 | 1979 | 25 | 0.010 |
Why?
| | Peroxides | 1 | 1979 | 19 | 0.010 |
Why?
| | Chemistry | 1 | 1979 | 41 | 0.010 |
Why?
| | Depression, Chemical | 1 | 1979 | 16 | 0.010 |
Why?
| | Electromagnetic Phenomena | 1 | 1979 | 24 | 0.010 |
Why?
| | Anesthesia, Local | 1 | 1979 | 25 | 0.010 |
Why?
| | Butyrates | 1 | 1979 | 67 | 0.010 |
Why?
| | Aldehydes | 1 | 1979 | 142 | 0.010 |
Why?
| | Blastomyces | 1 | 1978 | 9 | 0.010 |
Why?
| | Immune Sera | 1 | 1978 | 77 | 0.010 |
Why?
| | Heterozygote | 1 | 1979 | 315 | 0.010 |
Why?
| | Immunoglobulins | 1 | 1978 | 160 | 0.010 |
Why?
| | Bronchoscopy | 1 | 1979 | 227 | 0.010 |
Why?
| | Diagnosis, Differential | 1 | 1982 | 1489 | 0.010 |
Why?
| | Species Specificity | 1 | 1978 | 574 | 0.010 |
Why?
| | Hypergammaglobulinemia | 1 | 1976 | 8 | 0.010 |
Why?
| | Phenylbutazone | 1 | 1976 | 4 | 0.010 |
Why?
| | Glycolysis | 1 | 1978 | 339 | 0.010 |
Why?
| | Leucine Zippers | 1 | 1996 | 17 | 0.010 |
Why?
| | Oligonucleotide Probes | 1 | 1996 | 50 | 0.010 |
Why?
| | CCAAT-Enhancer-Binding Proteins | 1 | 1996 | 38 | 0.010 |
Why?
| | Eczema | 1 | 1976 | 66 | 0.010 |
Why?
| | Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 1995 | 5 | 0.010 |
Why?
| | Syndrome | 1 | 1976 | 380 | 0.010 |
Why?
| | Immunologic Deficiency Syndromes | 1 | 1975 | 65 | 0.010 |
Why?
| | Platelet Aggregation | 1 | 1975 | 105 | 0.010 |
Why?
| | Mitochondria, Liver | 1 | 1995 | 70 | 0.010 |
Why?
| | Genes, Dominant | 1 | 1975 | 101 | 0.010 |
Why?
| | Genes, Recessive | 1 | 1995 | 78 | 0.010 |
Why?
| | Protons | 1 | 1995 | 95 | 0.010 |
Why?
| | Immunoglobulin E | 1 | 1976 | 315 | 0.010 |
Why?
| | Fungal Proteins | 1 | 1995 | 145 | 0.010 |
Why?
| | Carbon Radioisotopes | 1 | 1974 | 29 | 0.010 |
Why?
| | Inclusion Bodies | 1 | 1974 | 27 | 0.010 |
Why?
| | Coloring Agents | 1 | 1974 | 93 | 0.010 |
Why?
| | Staphylococcus | 1 | 1974 | 74 | 0.010 |
Why?
| | Spleen | 1 | 1996 | 508 | 0.010 |
Why?
| | Rats, Inbred F344 | 1 | 1994 | 268 | 0.010 |
Why?
| | Vascular Diseases | 1 | 1975 | 251 | 0.010 |
Why?
| | Ibuprofen | 1 | 1992 | 84 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 1978 | 955 | 0.010 |
Why?
| | Solutions | 1 | 1991 | 166 | 0.010 |
Why?
| | Blood | 1 | 1991 | 109 | 0.010 |
Why?
| | Nuclear Proteins | 1 | 1996 | 748 | 0.010 |
Why?
| | Staining and Labeling | 1 | 1991 | 151 | 0.010 |
Why?
| | Nitroglycerin | 1 | 1990 | 14 | 0.000 |
Why?
| | Cold Temperature | 1 | 1991 | 209 | 0.000 |
Why?
| | Insulin | 1 | 1980 | 2507 | 0.000 |
Why?
| | Half-Life | 1 | 1989 | 151 | 0.000 |
Why?
| | Blood Gas Analysis | 1 | 1989 | 83 | 0.000 |
Why?
| | DNA-Binding Proteins | 1 | 1996 | 1499 | 0.000 |
Why?
| | Complement C9 | 1 | 1988 | 5 | 0.000 |
Why?
| | Microspheres | 1 | 1989 | 142 | 0.000 |
Why?
| | Child | 2 | 1979 | 22633 | 0.000 |
Why?
| | Fluoresceins | 1 | 1988 | 48 | 0.000 |
Why?
| | Complement C5 | 1 | 1988 | 33 | 0.000 |
Why?
| | Thiocyanates | 1 | 1988 | 28 | 0.000 |
Why?
| | Fluorescein-5-isothiocyanate | 1 | 1988 | 36 | 0.000 |
Why?
| | Coronary Vessels | 1 | 1990 | 251 | 0.000 |
Why?
| | Quinidine | 1 | 1987 | 5 | 0.000 |
Why?
| | Procainamide | 1 | 1987 | 6 | 0.000 |
Why?
| | Phenotype | 1 | 1976 | 3162 | 0.000 |
Why?
| | Virulence | 1 | 1988 | 278 | 0.000 |
Why?
| | Heparin | 1 | 1988 | 244 | 0.000 |
Why?
| | Fluorescent Dyes | 1 | 1988 | 329 | 0.000 |
Why?
| | Anti-Bacterial Agents | 1 | 1976 | 1907 | 0.000 |
Why?
| | Aorta, Thoracic | 1 | 1988 | 286 | 0.000 |
Why?
| | Swine | 1 | 1988 | 833 | 0.000 |
Why?
| | Stroke Volume | 1 | 1988 | 651 | 0.000 |
Why?
| | Pleura | 1 | 1983 | 28 | 0.000 |
Why?
| | Cytochalasin B | 1 | 1982 | 8 | 0.000 |
Why?
| | Micropore Filters | 1 | 1982 | 4 | 0.000 |
Why?
| | Transducers, Pressure | 1 | 1982 | 12 | 0.000 |
Why?
| | Ultrafiltration | 1 | 1982 | 30 | 0.000 |
Why?
| | Polysaccharides, Bacterial | 1 | 1981 | 67 | 0.000 |
Why?
| | Tritium | 1 | 1980 | 68 | 0.000 |
Why?
| | Cytoplasmic Granules | 1 | 1979 | 74 | 0.000 |
Why?
| | Microvilli | 1 | 1978 | 75 | 0.000 |
Why?
| | Myristates | 1 | 1977 | 1 | 0.000 |
Why?
| | Histocompatibility Testing | 1 | 1975 | 121 | 0.000 |
Why?
|
|
Repine's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|